On October 9, the Daily Mail said a citrus supplement ‘could help to banish lipoedema’, a condition of abnormal fat and swollen legs. Its story calls it incurable and quotes a surgeon saying the compounds do not treat it. Banish is a verb of removal: the thing is gone and stays gone. The Daily Mail’s own twelfth paragraph calls lipoedema “a condition that has no cure”, and near the end consultant plastic surgeon Vasu Karri says the compounds “will not reduce lipoedema fat.” The headline promises what the page takes back. A reader who stops at the headline leaves with the promise. A reader who reaches the end leaves with a surgeon saying no. Behind the promise stands one woman, 66, who took the citrus compounds “alongside several other supplements” and says her legs felt lighter within a fortnight. The story reports no measurement of fat or swelling and cites no trial. It leans on a 2021 US guideline whose diosmin line came from 21 experts reaching consensus, graded C, its lowest evidence grade. The one registered lipedema study of a diosmin product, which the Mail does not cite, is sponsored by its maker, Primus Pharmaceuticals: an estimated 30 women, all knowing what they take. The tell is the hedge in front of the big verb: when “could help to” stands before a cure word, the cure word is the sale. The story names no brand, only a price, “around £20 for a two-month supply”, and does not say who sells it. NHS care is compression garments, exercise, weight management and pain relief, with liposuction not routinely available. Beside that slow list, a capsule is the easiest hope on the page.
